Quantedge Capital Pte LTD Amphastar Pharmaceuticals, Inc. Transaction History

Quantedge Capital Pte LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$45.51 - $65.0 $241,203 - $344,500	5,300 Added 17.05%	36,389 $1.67 Million
Q2 2023 Aug 11, 2023	BUY	$35.77 - $58.38 $883,519 - $1.44 Million	24,700 Added 386.6%	31,089 $1.79 Million
Q1 2023 May 12, 2023	SELL	$27.99 - $37.92 $805,104 - $1.09 Million	-28,764 Reduced 81.83%	6,389 $239,000
Q4 2022 Feb 14, 2023	SELL	$27.93 - $31.27 $1.98 Million - $2.22 Million	-71,047 Reduced 66.9%	35,153 $984,000
Q3 2022 Nov 10, 2022	SELL	$27.56 - $37.75 $421,668 - $577,575	-15,300 Reduced 12.59%	106,200 $2.98 Million
Q2 2022 Aug 12, 2022	BUY	$29.79 - $42.29 $2.69 Million - $3.82 Million	90,400 Added 290.68%	121,500 $4.23 Million
Q1 2022 May 13, 2022	BUY	$22.96 - $36.45 $714,056 - $1.13 Million	31,100 New	31,100 $1.12 Million

279

36.5M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.79B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Quantedge Capital Pte LTD, based on Form 13F filings with the SEC.

Stay updated on Quantedge Capital Pte LTD with notifications on news.